Efficacy and safety of mifepristone-misoprostol combination with extraamniotic ethacridine lactate-misoprostol for termination of second trimester pregnancy
Keywords:Abortion rate, Ethacridine lactate, Induction-abortion interval, Mifepristone, Misoprostol, Side effects, Second trimester abortion
Background: Mid trimester termination of pregnancy is one of the most controversial areas of gynecological practice. It has moral, emotional, social and technical issues. This study was designed for comparison of efficacy and safety of Mifepristone-Misoprostol combination with exrtaamniotic Ethacridine Lactate-misoprostol for termination of second trimester pregnancy.
Methods: The present was undertaken among the patients admitted to hospitals attached to J.J.M. Medical College; Bapuji hospital, Women and Children hospital and Chigateri general hospital Davangere during the study period from November 2016 - October 2017. Patients coming for second trimester abortion to above mentioned hospitals were assigned serial number from 1 to 80 and all patients with even number will be allocated to group 1 and all patients with odd number will be allocated in group 2, each group comprising 40 women each.
Results: Majority of the cases in both the groups were between 21-25 yrs. Majority of the cases in both the groups were multigravidas. 11 cases from group 1 and 12 cases from group 2 were of gestational age between 14-16 wks. 29 cases from group 1 and 28 cases from group 2 were of gestational age between 18-20 wks. In the present study the mean induction abortion interval for group 1 was 19.56±1.82 hours and group 2 was 14.13±2.72 hours. This was statistically significant. Of the 40 cases in each group, 37 had complete abortion i.e. 92.5% 3 cases (7.5%) from both the groups had incomplete abortion. The side effects were relatively more in more in group 1 when compared to group 2.
Conclusions: It was concluded that with this combination success rate was high (92.5 %), with Short induction abortion interval, less rate of incomplete abortion without any major complications.
Biswas SC, Dey R, Jana R, Chattopadhya N. Comparative study of intravaginal misoprostol and extraamniotic ethacridine lactate instillation for mid trimester pregnancy termination. J Obstet Gynecol India. 2007;57(3):210-12.
Jyothi IS, Reddy KA, Saritha A. Comparative Study of Efficacy of Extra-amniotic Ethacridine Lactate with Oxytocin Versus Extra-amniotic Ethacridine Lactate with Intravaginal Misoprostol for Termination of Pregnancy with IUD Anamolous Fetuses in Second and Third Trimesters. Indian J Med Allied Sci. 2015;3(3):155-60
Nagaria T, Sirmor N. Misoprostol versus mifepristone and misoprostol in second trimester termination of pregnancy. J Obstet Gynecol India. 2011;61(6):659-62.
Chaudhuri S, Mitra SN, Chaudhuri N, Chattopadhya D, Banerjee D, Bose S. A comparison of intravaginal misoprostol with extraamniotic etharidine lactate for second trimester MTP. J Obstet and Gynecol India. 2006;56(6):518-21
Shaw KA, Topp NJ, Shaw JG, Blumenthal PD. Mifepristone–Misoprostol Dosing Interval and Effect on Induction Abortion Times: A Systematic Review. Obstet Gynecol. 2013 Jun 1;121(6):1335-47.
Velazco Boza A, Gómez Ponce de León R, Salas Castillo L, Yi Mariño DR, Mitchell EM. Misoprostol Preferable to Ethacridine Lactate for Abortions at 13–20 Weeks of Pregnancy:Cuban Exp. Reproductive Health Matters. 2008;16(31):189-95
Nanda S, Paul A. Comparison of efficacy and safety of mifepristone-misoprostol combination with ethacridine lactate in mid-trimester termination of pregnancy. Int J Medicine Medical Sci. 2013;5(6):307-11.
Mamta G, Kant SK, Ramavatar B, Gupta S. Comparative Study of Intravaginal Misoprostol Alone 'Versus' Extra Amniotic Ethacridine Lactate Instillation Followed by Intravaginal Misoprostol'for Mid Trimester (13-20 Weeks) Termination of Pregnancy. IOSR-JDMS.2016;1(15):129-32.
Yashvardhini S, Himabindu S. A comparative study of ethacridine lactate with vaginal misoprostol versus vaginal misoprostol alone for mid trimester abortion. IAIM, 2017;4(6):38-44
Patil N, Gupta P, Hittinhalli MD, Mudanur SR, Tehalia MKJ, Nemagouda AS et al. A randomised controlled trial to compare the efficacy of preinduction with mifepristone 12 hours versus 24 hours prior for second trimister pregnancy termination. Int J Reprod Contracept Obstet Gynecol. 2017;6(8):3628-32.